A New Milestone, Six Years in the Making For the past six years, Susan Fuhs of Virginia Beach has turned her own ovarian cancer diagnosis into an annual invitation for others to get involved, get educated, and give back. Susan is the longtime organizer behind the Fitness & Fight fundraising event in Virginia Beach—an event … Continued
Ovarian Cycle is back in Rio Grande Valley on September 19, and KRGV-TV Channel 5 News (ABC) recently sat down with Marlynn Olivarez, organizer of the fundraiser, to talk about the event and why it matters. Over the past 10 years, the Rio Grande Valley community has raised more than $66,000 for ovarian and gynecologic cancer research … Continued
Nearly 1,000 runners, walkers, survivors, families, friends, and supporters gathered at Seattle’s Seward Park on Sunday, July 12, 2026, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. This year’s event raised more than $260,000. Now in its 33rd year, the event once again transformed the park into a sea of teal and purple, … Continued
SEATTLE, WA, July 9, 2026 — Nearly 1,000 runners, walkers, survivors, families, friends, and supporters are expected to gather at Seward Park on Sunday, July 12, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, one of the nation’s longest-running events dedicated to funding ovarian cancer research. Participants of all ages and abilities will transform … Continued
Accelerating the Mission: OCRA President & CEO Audra Moran Named a Crain’s 2026 Notable Leader in Health Care Ovarian Cancer Research Alliance (OCRA) is proud to share that President and CEO Audra Moran has been named a Crain’s New York Business 2026 Notable Leader in Health Care—an annual recognition honoring executives whose leadership, innovation, and … Continued
In a recent article, Mercer Island Reporter journalist Andy Nystrom looks at the history and ongoing impact of the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, the iconic annual 5K Run/Walk event that continues to play a vital role in raising funds for ovarian cancer research. Join the 2025 SummeRun in Seattle This year’s … Continued
OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective April 1, 2025. This historic collaboration unites two respected organizations committed to advancing research for a cure for ovarian and all gynecologic cancers. “OCRA has always … Continued
Ovarian Cancer Research Alliance hosted a free online seminar for the ovarian and gynecologic cancer community on September 19th to share important information about genetics, biomarkers, and the latest in precision medicine for ovarian and related gynecologic cancers. Dr. Barbara Norquist of the University of Washington and Dr. Ying Liu of Memorial Sloan Kettering Cancer … Continued
Help OCRA Make an Impact for Ovarian Cancer and Gynecologic Cancer Awareness Month September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. As the largest non-profit in the world combating ovarian and gynecologic cancers, OCRA is committing to raise $300,000 this September to accelerate progress in research, advocate for our community, and continue … Continued
OCRA’s National Conference begins November 1st Join us virtually from November 1st – 3rd for three days of information, community and resources. Attendees will learn the latest updates in research, treatment and care, straight from the experts — in language you don’t have to be a doctor to understand. New this year, our experts will … Continued
OCRA-Funded Study Targets Immunotherapy OCRA grantees and their Roswell Park Comprehensive Cancer Center colleagues published results from an exciting study detailing a new approach to adoptive T-cell therapy that may help improve immunotherapy options for ovarian cancer patients. Learn more about the findings from the research team, which included Dr. Bob McGray, OCRA grantee, and Dr. Kunle Odunsi, … Continued
What to Know About the Chemotherapy Drug Shortage As many are aware, the U.S. is currently experiencing a matter of great concern: an ongoing shortage of chemotherapy drugs that are essential in the treatment of ovarian cancer. The availability of these medications is of critical importance to patients and their families, and we understand the anxiety … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
